VP
DTIL icon

venBio Partners’s Precision BioSciences DTIL Stock Holding History

venBio Partners’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-43,273
Closed -$8M – 8
2020
Q3 		$8M Sell
43,273
-49,780
-53% -$9.9M 1.22% 7
2020
Q2 		$23.3M Sell
93,053
-40,544
-30% -$8.88M 19.33% 2
2020
Q1 		$24.2M Sell
133,597
-8,574
-6% -$2.24M 20.6% 2
2019
Q4 		$59.2M Hold
142,171
– – 25.4% 2
2019
Q3 		$35.8M Hold
142,171
– – 16.98% 3
2019
Q2 		$56.5M Hold
142,171
– – 25.08% 2
2019
Q1 		$76.6M Buy
+142,171
New +$75.5M 62% 1

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
WHAM
Windmill Hill Asset Management Waddesdon, United Kingdom $448M AUM 23.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

venBio Partners's DTIL Position: Q4 2020 in Review

venBio Partners sold out of Precision BioSciences (DTIL) in Q4 2020, closing a stake of 43,273 shares — an estimated $8M sold.

venBio Partners first reported a position in DTIL in Q1 2019 and held it in 7 quarters. The position peaked at $76.6M in Q1 2019. 118 funds tracked by Wall St. Rank hold DTIL as of Q4 2020.

  • venBio Partners reported no remaining Precision BioSciences position as of Q4 2020 after selling out during the quarter.
  • venBio Partners sold 43,273 Precision BioSciences shares in Q4 2020, an estimated $8M.
  • venBio Partners first reported a position in Precision BioSciences in Q1 2019 and held it in 7 quarters.
  • venBio Partners's Precision BioSciences position peaked at $76.6M in Q1 2019.
  • 118 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2020.

Based on venBio Partners's 13F filing for Q4 2020, filed 16 Feb 2021.